IRWD

Ironwood Pharmaceuticals, Inc. Press Releases

$10.75
*  
0.01
0.09%
Get IRWD Alerts
*Delayed - data as of May 3, 2016 13:39 ET  -  Find a broker to begin trading IRWD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IRWD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ironwood Pharmaceuticals, Inc. - IRWD
4/28/2016 11:27:00 AM - PR Newswire
▲0.66 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Ironwood Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
4/27/2016 6:09:00 PM - Business Wire
▲2.48 % Price Change since this news event. The Volume Ratio is 0.93.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Investigated for Potential Violations of Federal Securities Laws by Block & Leviton LLP
4/26/2016 12:04:00 PM - PR Newswire
▲7.50 % Price Change since this news event. The Volume Ratio is 8.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
4/26/2016 5:07:00 AM - Business Wire
▼-0.92 % Price Change since this news event. The Volume Ratio is 10.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
4/25/2016 4:01:00 PM - Business Wire
▼-0.92 % Price Change since this news event. The Volume Ratio is 10.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
4/7/2016 8:00:00 AM - Business Wire
▼-8.43 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis
4/5/2016 8:00:00 AM - Business Wire
▲2.38 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
3/30/2016 8:00:00 AM - Business Wire
▲3.17 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
3/23/2016 8:00:00 AM - Business Wire
▼-0.56 % Price Change since this news event. The Volume Ratio is 0.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
3/9/2016 4:01:00 PM - Business Wire
▼-0.09 % Price Change since this news event. The Volume Ratio is 0.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
3/1/2016 4:01:00 PM - Business Wire
▲4.98 % Price Change since this news event. The Volume Ratio is 1.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Video Alert: Updated 2016 Direct-to-Consumer Awareness Campaign Available for LINZESS® (linaclotide)
2/29/2016 4:05:00 PM - Business Wire
▲11.40 % Price Change since this news event. The Volume Ratio is 1.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
2/24/2016 8:00:00 AM - Business Wire
▲21.61 % Price Change since this news event. The Volume Ratio is 0.93.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
2/18/2016 4:05:00 PM - Business Wire
▲25.15 % Price Change since this news event. The Volume Ratio is 2.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
2/18/2016 8:00:00 AM - Business Wire
▲25.73 % Price Change since this news event. The Volume Ratio is 2.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference
2/17/2016 4:01:00 PM - Business Wire
▲22.72 % Price Change since this news event. The Volume Ratio is 2.37.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
2/4/2016 4:01:00 PM - Business Wire
▲18.39 % Price Change since this news event. The Volume Ratio is 2.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day